[1] |
KHUSH KK, CHERIKH WS, CHAMBERS DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult heart transplantation report - 2019; focus theme: donor and recipient size match[J]. J Heart Lung Transplant, 2019, 38(10): 1056-1066. DOI: 10.1016/j.healun.2019.08.004.
|
[2] |
CHRISTIE JD, VAN RAEMDONCK D, DE PERROT M, et al. Report of the ISHLT working group on primary lung graft dysfunction part I: introduction and methods[J]. J Heart Lung Transplant, 2005, 24(10): 1451-1453. DOI: 10.1016/j.healun.2005.03.004.
|
[3] |
PORTEOUS MK, LEE JC. Primary graft dysfunction after lung transplantation[J]. Clin Chest Med, 2017, 38(4): 641-654. DOI: 10.1016/j.ccm.2017.07.005.
|
[4] |
DIAMOND JM, ARCASOY S, KENNEDY CC, et al. Report of the International Society for Heart and Lung Transplantation Working Group on primary lung graft dysfunction, part Ⅱ: epidemiology, risk factors, and outcomes-a 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation[J]. J Heart Lung Transplant, 2017, 36(10): 1104-1113. DOI: 10.1016/j.healun.2017.07.020.
|
[5] |
JIN Z, SUEN KC, WANG Z, et al. Review 2: primary graft dysfunction after lung transplant-pathophysiology, clinical considerations and therapeutic targets[J]. J Anesth, 2020, 34(5): 729-740. DOI: 10.1007/s00540-020-02823-6.
|
[6] |
BHARAT A, KREISEL D. Immunopathogenesis of primary graft dysfunction after lung transplantation[J]. Ann Thorac Surg, 2018, 105(3): 671-674. DOI: 10.1016/j.athoracsur.2017.11.007.
|
[7] |
LIU Y, LIU Y, SU L, et al. Recipient-related clinical risk factors for primary graft dysfunction after lung transplantation: a systematic review and Meta-analysis[J]. PLoS One, 2014, 9(3): e92773. DOI: 10.1371/journal.pone.0092773.
|
[8] |
KUNTZ CL, HADJILIADIS D, AHYA VN, et al. Risk factors for early primary graft dysfunction after lung transplantation: a registry study[J]. Clin Transplant, 2009, 23(6): 819-830. DOI: 10.1111/j.1399-0012.2008.00951.x.
|
[9] |
PORTEOUS MK, LEE JC, LEDERER DJ, et al. Clinical risk factors and prognostic model for primary graft dysfunction after lung transplantation in patients with pulmonary hypertension[J]. Ann Am Thorac Soc, 2017, 14(10): 1514-1522. DOI: 10.1513/AnnalsATS.201610-810OC.
|
[10] |
LOWERY EM, KUHLMANN EA, MAHONEY EL, et al. Heavy alcohol use in lung donors increases the risk for primary graft dysfunction[J]. Alcohol Clin Exp Res, 2014, 38(11): 2853-2861. DOI: 10.1111/acer.12553.
|
[11] |
PELAEZ A, MITCHELL PO, SHAH NS, et al. The role of donor chronic alcohol abuse in the development of primary graft dysfunction in lung transplant recipients[J]. Am J Med Sci, 2015, 349(2): 117-123. DOI: 10.1097/MAJ.0000000000000361.
|
[12] |
CAMARGO MORENO M, LEWIS JB, KOVACS EJ, et al. Lung allograft donors with excessive alcohol use have increased levels of human antimicrobial peptide LL-37[J]. Alcohol, 2019, 80: 109-117. DOI: 10.1016/j.alcohol.2018.11.003.
|
[13] |
WILKEY BJ, ABRAMS BA. Mitigation of primary graft dysfunction in lung transplantation: current understanding and hopes for the future[J]. Semin Cardiothorac Vasc Anesth, 2020, 24(1): 54-66. DOI: 10.1177/1089253219881980.
|
[14] |
EBERLEIN M, REED RM, BOLUKBAS S, et al. Lung size mismatch and primary graft dysfunction after bilateral lung transplantation[J]. J Heart Lung Transplant, 2015, 34(2): 233-240. DOI: 10.1016/j.healun.2014.09.030.
|
[15] |
PALLESCHI A, ROSSO L, MUSSO V, et al. Lung transplantation from donation after controlled cardiocirculatory death. systematic review and Meta-analysis[J]. Transplant Rev (Orlando), 2020, 34(1): 100513. DOI: 10.1016/j.trre.2019.100513.
|
[16] |
VILLAVICENCIO MA, AXTELL AL, SPENCER PJ, et al. Lung transplantation from donation after circulatory death: United States and single-center experience[J]. Ann Thorac Surg, 2018, 106(6): 1619-1627. DOI: 10.1016/j.athoracsur.2018.07.024.
|
[17] |
COSTA J, SHAH L, ROBBINS H, et al. Use of lung allografts from donation after cardiac death donors: a single-center experience[J]. Ann Thorac Surg, 2018, 105(1): 271-278. DOI: 10.1016/j.athoracsur.2017.07.023.
|
[18] |
THUONG M, RUIZ A, EVRARD P, et al. New classification of donation after circulatory death donors definitions and terminology[J]. Transpl Int, 2016, 29(7): 749-759. DOI: 10.1111/tri.12776.
|
[19] |
BOFFINI M, RICCI D, BONATO R, et al. Incidence and severity of primary graft dysfunction after lung transplantation using rejected grafts reconditioned with ex vivo lung perfusion[J]. Eur J Cardiothorac Surg, 2014, 46(5): 789-793. DOI: 10.1093/ejcts/ezu239.
|
[20] |
LIU F, LU Y, WEI D, et al. Effect of ex vivo lung perfusion on storage of isolated lungs[J]. Ann Palliat Med, 2020, 9(2): 359-367. DOI: 10.21037/apm.2020.03.08.
|
[21] |
WONG A, ZAMEL R, YEUNG J, et al. Potential therapeutic targets for lung repair during human ex vivo lung perfusion[J]. Eur Respir J, 2020, 55(4): 1902222. DOI: 10.1183/13993003.02222-2019.
|
[22] |
TANE S, NODA K, TOYODA Y, et al. Bronchial-arterial-circulation-sparing lung preservation: a new organ protection approach for lung transplantation[J]. Transplantation, 2020, 104(3): 490-499. DOI: 10.1097/TP.0000000000002984.
|
[23] |
OTO T, GRIFFITHS AP, ROSENFELDT F, et al. Early outcomes comparing Perfadex, Euro-Collins, and Papworth solutions in lung transplantation[J]. Ann Thorac Surg, 2006, 82(5): 1842-1848. DOI: 10.1016/j.athoracsur.2006.05.088.
|
[24] |
AL-NAAMANI N, PAN HM, ANDERSON MR, et al. Thoracic visceral adipose tissue area and pulmonary hypertension in lung transplant candidates. the lung transplant body composition study[J]. Ann Am Thorac Soc, 2020, 17(11): 1393-1400. DOI: 10.1513/AnnalsATS.202003-247OC.
|
[25] |
ANDERSON MR, UDUPA JK, EDWIN E, et al. Adipose tissue quantification and primary graft dysfunction after lung transplantation: The Lung Transplant Body Composition study[J]. J Heart Lung Transplant, 2019, 38(12): 1246-1256. DOI: 10.1016/j.healun.2019.08.013.
|
[26] |
LEE JC, CHRISTIE JD. Primary graft dysfunction[J]. Clin Chest Med, 2011, 32(2): 279-293. DOI: 10.1016/j.ccm.2011.02.007.
|
[27] |
HU CX, CHEN WH, HE JX, et al. Lung transplantation in China between 2015 and 2018[J]. Chin Med J (Engl), 2019, 132(23): 2783-2789. DOI: 10.1097/CM9. 0000000000000543.
|
[28] |
GEUBE MA, PEREZ-PROTTO SE, MCGRATH TL, et al. Increased intraoperative fluid administration is associated with severe primary graft dysfunction after lung transplantation[J]. Anesth Analg, 2016, 122(4): 1081-1088. DOI: 10.1213/ANE.0000000000001163.
|
[29] |
WANG X, O'BRIEN ME, YU J, et al. Prolonged cold ischemia induces necroptotic cell death in ischemia-reperfusion injury and contributes to primary graft dysfunction after lung transplantation[J]. Am J Respir Cell Mol Biol, 2019, 61(2): 244-256. DOI: 10.1165/rcmb.2018-0207OC.
|
[30] |
KIZILTUG H, FALTER F. Circulatory support during lung transplantation[J]. Curr Opin Anaesthesiol, 2020, 33(1): 37-42. DOI: 10.1097/ACO.0000000000000806.
|
[31] |
MAGOULIOTIS DE, TASIOPOULOU VS, SVOKOS AA, et al. Extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation: a Meta-analysis[J]. Gen Thorac Cardiovasc Surg, 2018, 66(1): 38-47. DOI: 10.1007/s11748-017-0836-3.
|
[32] |
HAYANGA JWA, CHAN EG, MUSGROVE K, et al. Extracorporeal membrane oxygenation in the perioperative care of the lung transplant patient[J]. Semin Cardiothorac Vasc Anesth, 2020, 24(1): 45-53. DOI: 10.1177/1089253219896123.
|
[33] |
HOETZENECKER K, BENAZZO A, STORK T, et al. Bilateral lung transplantation on intraoperative extracorporeal membrane oxygenator: an observational study[J]. J Thorac Cardiovasc Surg, 2020, 160(1): 320-327. DOI: 10.1016/j.jtcvs.2019.10.155.
|
[34] |
FRICK AE, ORLITOVÁ M, VANSTAPEL A, et al. A novel experimental porcine model to assess the impact of differential pulmonary blood flow on ischemia-reperfusion injury after unilateral lung transplantation[J]. Intensive Care Med Exp, 2021, 9(1): 4. DOI: 10.1186/s40635-021-00371-1.
|
[35] |
SUNDER T. Extracorporeal membrane oxygenation and lung transplantation[J]. Indian J Thorac Cardiovasc Surg, 2021, 19: 1-11. DOI: 10.1007/s12055-020-01099-5.
|
[36] |
MITZMAN B. Commentary: taking matters into your own hands: venoarterial extracorporeal membrane oxygenation for controlled reperfusion during lung transplantation[J]. J Thorac Cardiovasc Surg, 2020, 160(1): 330-331. DOI: 10.1016/j.jtcvs.2019.11.037.
|
[37] |
PENA JJ, BOTTIGER BA, MILTIADES AN. Perioperative management of bleeding and transfusion for lung transplantation[J]. Semin Cardiothorac Vasc Anesth, 2020, 24(1): 74-83. DOI: 10.1177/1089253219869030.
|
[38] |
SEAY T, GUINN N, MAISONAVE Y, et al. The association of increased FFP: RBC transfusion ratio to primary graft dysfunction in bleeding lung transplantation patients[J]. J Cardiothorac Vasc Anesth, 2020, 34(11): 3024-3032. DOI: 10.1053/j.jvca.2020.05.043.
|
[39] |
SYRETT AJ, HUANG A. Transfusion and primary graft dysfunction after lung transplantation: all about the ratio?[J]. J Cardiothorac Vasc Anesth, 2020, 34(11): 3033-3035. DOI: 10.1053/j.jvca.2020.07.012.
|
[40] |
胡春晓, 王志萍, 许波, 等. 肺移植术中肺动脉高压的麻醉管理[J]. 中华器官移植杂志, 2019, 40(3): 189-192. DOI: 10.3760/cma.j.issn.0254-1785.2019.03.017.HU CX, WANG ZP, XU B, et al. Anesthesia management of pulmonary hypertension during lung transplantation[J]. Chin J Organ Transplant, 2019, 40(3): 189-192. DOI: 10.3760/cma.j.issn.0254-1785.2019.03.017.
|
[41] |
KACHULIS B, MITREV L, JORDAN D. Intraoperative anesthetic management of lung transplantation patients[J]. Best Pract Res Clin Anaesthesiol, 2017, 31(2): 261-272. DOI: 10.1016/j.bpa.2017.04.004.
|
[42] |
中华医学会麻醉学分会"肺移植术麻醉管理专家共识"工作小组. 肺移植术麻醉管理专家共识[J]. 中华麻醉学杂志, 2020, 40(7): 771-778. DOI: 10.3760/cma.j.cn131073.20200508.00702.Task Force on Anaesthesia Management for Lung Transplantation of Branch of Anesthesiology of Chinese Medical Association. Expert consensus on anaesthesia management for lung transplantation[J]. Chin J Anesthesiol, 2020, 40(7): 771-778. DOI: 10.3760/cma.j.cn131073.20200508.00702.
|
[43] |
YAMADA Y, LAUBE I, JANG JH, et al. Sevoflurane preconditioning protects from posttransplant injury in mouse lung transplantation[J]. J Surg Res, 2017, 214: 270-277. DOI: 10.1016/j.jss.2017.03.021.
|
[44] |
MARTIN AK, YALAMURI SM, WILKEY BJ, et al. The impact of anesthetic management on perioperative outcomes in lung transplantation[J]. J Cardiothorac Vasc Anesth, 2020, 34(6): 1669-1680. DOI: 10.1053/j.jvca.2019.08.037.
|